Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market
完整報告名稱與涵蓋範圍
Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Size, Share & Trends Analysis Report, By Service Type (Cryogenic Storage and Cold Chain Transportation, Supply Chain Orchestration and Chain-of-Identity Software, Apheresis and Starting Material Collection Coordination, Packaging, Labelling and Distribution Services), By Therapy Type (Autologous Cell Therapies, Allogeneic Cell Therapies, Gene Therapies and Viral Vectors), By Temperature Requirement (Cryogenic (Below -150C), Frozen and Refrigerated, Ambient and Controlled Room Temperature), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The cell and gene therapy supply chain and vein-to-vein logistics market covers the specialised cold chain, cryogenic storage, orchestration software and coordination services that move patient cells, manufactured therapies and viral vectors between treatment centers, manufacturing sites and storage facilities with full chain of identity and custody. Conventional pharmaceutical cold chain logistics and the manufacturing of therapies themselves are excluded.
Demand scales directly with commercial CAR-T volumes, approved gene therapies and a clinical pipeline in which every autologous dose is a unique batch tied to a single patient and schedule. Each therapy requires apheresis scheduling, temperature-controlled transport in liquid nitrogen shippers, storage under validated cryogenic conditions, real-time tracking and software that links patient identity to every manufacturing and shipping event. Providers are building global cryogenic storage networks, integrated orchestration platforms that connect hospitals, manufacturers and couriers, and services for allogeneic products that shift the model toward inventory-based distribution. Regulatory expectations for traceability, the cost of logistics as a share of therapy price and the expansion of treatment centers into community settings drive investment.
North America and Europe account for most volume, with China, Japan and South Korea expanding rapidly as domestic cell therapies gain approval. Competition combines specialised cryogenic logistics companies, global healthcare couriers, orchestration software vendors and storage and consumables providers.
The InsightAce study provides US$ revenue forecasts for every service type, therapy type, temperature requirement and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Snapshot
Chapter 4. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Cryogenic Storage and Cold Chain Transportation
5.2.2. Supply Chain Orchestration and Chain-of-Identity Software
5.2.3. Apheresis and Starting Material Collection Coordination
5.2.4. Packaging, Labelling and Distribution Services
Chapter 6. Market Segmentation 2: By Therapy Type Estimates & Trend Analysis
6.1. Therapy Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapy Type:
6.2.1. Autologous Cell Therapies
6.2.2. Allogeneic Cell Therapies
6.2.3. Gene Therapies and Viral Vectors
Chapter 7. Market Segmentation 3: By Temperature Requirement Estimates & Trend Analysis
7.1. Temperature Requirement & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Temperature Requirement:
7.2.1. Cryogenic (Below -150C)
7.2.2. Frozen and Refrigerated
7.2.3. Ambient and Controlled Room Temperature
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Cell and Gene Therapy Developers
8.2.2. Treatment Centers and Hospitals
8.2.3. CDMOs and Manufacturing Partners
Chapter 9. Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Cryoport, Inc.
11.2. Thermo Fisher Scientific Inc. (Fisher Clinical Services)
11.3. BioLife Solutions, Inc.
11.4. Marken (UPS Healthcare)
11.5. World Courier (Cencora)
11.6. Azenta Life Sciences
11.7. Vineti (Accenture)
11.8. TrakCel Limited
11.9. Be The Match BioTherapies (NMDP)
11.10. Quick International Courier
11.11. DHL Supply Chain (Life Sciences)
11.12. Catalent Cell & Gene Therapy (Novo Nordisk A/S)
11.13. Cryogene (BioLife Solutions)
11.14. MVE Biological Solutions (Cryoport)
11.15. Ori Biotech Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Segmentation and Scope Overview
Table 2. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue Forecast by Therapy Type, 2026-2035 (US$ Mn)
Figure 2. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Share by Service Type, 2026 & 2035
Table 3. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue Forecast by Temperature Requirement, 2026-2035 (US$ Mn)
Figure 3. Vein-to-Vein Workflow for Autologous Cell Therapy with Chain-of-Identity Control Points
Table 4. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Cryogenic Storage and Transport Network Capacity by Region, 2026-2035
Table 5. Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Growth Opportunity Analysis
Table 6. North America Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Participants
Table 7. Europe Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market
Table 8. Asia Pacific Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Logistics Cost Share and Turnaround Time Benchmarks Across Cell and Gene Therapy Products
Table 9. Strategic Developments of Leading Cell & Gene Therapy Supply Chain & Vein-to-Vein Logistics Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們